Goldman Sachs Group »

Xenon Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 376k 46.06
2023-09-30 $8.7M 255k 34.16
2023-06-30 $11M 275k 38.50
2023-03-31 $10M 285k 35.79
2022-12-31 $11M 284k 39.43
2022-06-30 $9.0M 296k 30.42
2022-03-31 $22M 724k 30.57
2021-12-31 $5.4M 171k 31.24
2021-09-30 $1.5M 96k 15.28
2021-03-31 $2.4M 135k 17.90
2020-12-31 $2.1M 138k 15.38
2020-09-30 $686k 62k 11.07
2020-06-30 $367k 29k 12.54
2019-12-31 $170k 13k 13.14
2019-09-30 $95k 11k 9.02
2019-03-31 $124k 12k 10.13
2018-12-31 $80k 13k 6.32
2015-03-31 $202k 12k 16.83
2014-12-31 $411k 21k 19.76